318 filings
Page 6 of 16
8-K
ccjh75zoy b7a
29 Jun 16
Regulation FD Disclosure
12:00am
8-K
03q0se
29 Apr 16
Anthera Pharmaceuticals Appoints Brent Furse to Board of Directors
12:00am
424B5
5m07yc 5h49c3rda6q2t
29 Apr 16
Prospectus supplement for primary offering
12:00am
8-K
c0s5nbawdw656c mz7v
22 Apr 16
Entry into a Material Definitive Agreement
12:00am
424B5
tqfq6p2292ktth
22 Apr 16
Prospectus supplement for primary offering
12:00am
EFFECT
pck6rq6q
18 Apr 16
Notice of effectiveness
12:00am
CORRESP
iy7ubiy pb2198bdbbk
13 Apr 16
Correspondence with SEC
12:00am
UPLOAD
tv4irohkxzz4pir
23 Mar 16
Letter from SEC
12:00am
DEFA14A
ov9lvgnnbhuuijq8z eb
17 Mar 16
Additional proxy soliciting materials
12:00am
DEFA14A
5vf0s17hsi
15 Mar 16
Additional proxy soliciting materials
12:00am
8-K
db1 2vm3ublq
10 Mar 16
Anthera Pharmaceuticals Provides Business Update and Reports 2015 Fourth Quarter and Fiscal Year Financial Results
12:00am
8-K
7qhu r2b3b
8 Mar 16
Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer
12:00am
8-K
rcbtmkwk88tqa9ia y4
17 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
28fu0te15o7l8 z8ej
29 Jan 16
Departure of Directors or Certain Officers
12:00am
8-K
jwyz2c6ocn 6d88n6i7
8 Jan 16
Departure of Directors or Certain Officers
12:00am